Targeted antibiotics may help protect against infections in men being tested for prostate cancer

prostate cancer
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia

A new review indicates that antimicrobial therapy given before clinicians take transrectal ultrasound-guided prostate biopsies to diagnose prostate cancer may lead to lower rates of sepsis, a potentially life-threatening infection.

The review, which included 9 studies in multiple countries, found that 27 men would need to receive targeted antibiotics to prevent one infective complication.

"In light of these findings we are planning to introduce rectal swabs and targeted as a necessary preparation for transrectal prostate biopsy," said Tim Dudderidge, consultant urological surgeon at Southampton General Hospital and senior author of the BJU International review.

"The only question is whether techniques involving multiparametric MRI of the prostate and targeted transperineal biopsy will make transrectal biopsy obsolete first."


Explore further

Testing for drug-resistant bacteria before prostate biopsy can reduce infections

More information: A Cussans et al. The role of targeted prophylactic antimicrobial therapy prior to transrectal ultrasound (TRUS) guided prostate biopsy in reducing infection rates: a systematic review, BJU International (2015). DOI: 10.1111/bju.13402
Provided by Wiley
Citation: Targeted antibiotics may help protect against infections in men being tested for prostate cancer (2016, February 1) retrieved 19 August 2019 from https://medicalxpress.com/news/2016-02-antibiotics-infections-men-prostate-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more